9 completed, 2 unknown. 11 Phase 1, 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 11 | Completed 9, Unknown 2 |
| Phase 2 | 5 | Completed 4, Unknown 1 |
Follow German Research Foundation: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Ghrelin Administration on Dopamine and Effort Ghrelin, Placebo - Major Depressive Disorder | Phase 1 / Phase 2 | Completed | University Hospital Tuebingen | 26 | 2022-02-21 | 2025-12-22 |
| Preventative/Preemptive Adoptive Transfer of Peptide Stimulated CMV/EBV Specific T-cells in Patients After Allogeneic Stem Cell Transplantation CMV/EBV specific T-cell - Patients Undergoing Allogeneic Stem Cell Transplantation | Phase 1 / Phase 2 | Completed | University of Erlangen-Nürnberg Medical School | 50 | 2014-10-01 | 2020-12-14 |
| Open-label Clinical Trial to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates for Immune Reconstitution After Allogeneic Stem Cell Transplantation Measured as Response to a Antedated Single Vaccination allogeneic donor derived B-lymphocytes - Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia | Phase 1 / Phase 2 | Unknown | University of Erlangen-Nürnberg Medical School | 15 | 2013-11-01 | 2014-03-26 |
| Safety Study of Preoperative Sunitinib and Radiation in Soft Tissue Sarcoma Sunitinib - Soft Tissue Sarcoma | Phase 1 | Completed | Heidelberg University | 9 | 2012-02-01 | 2017-08-28 |
| Adiponectin and Circulating Progenitor Cells (CPC) Function exercise training - Coronary Artery Disease | Phase 1 | Completed | University of Leipzig | 20 | 2011-01-01 | 2015-06-02 |
| Social Cognition,Attentional Network and Nicotine Drug Dependency - A Pharmacological Clinical Trail nicotine nasal spray - Tobacco Use Disorder, Schizophrenia | Phase 1 / Phase 2 | Completed | Heinrich-Heine University, Duesseldorf | 101 | 2008-01-01 | 2012-03-02 |
| A Randomized Controlled Clinical Trial With Orphans and Widows Who Experienced the Rwandan Genocide Narrative Exposure Therapy/Interpersonal Psychotherapy - Posttraumatic Stress Disorder, Depression | Phase 1 | Unknown | University of Konstanz | 150 | 2007-08-01 | 2007-11-06 |
| Vaccination With Tumor mRNA in Metastatic Melanoma - Fixed Combination Versus Individual Selection of Targeted Antigens mRNA coding for melanoma associated antigens, GM-CSF - Malignant Melanoma | Phase 1 / Phase 2 | Completed | University Hospital Tuebingen | 31 | 2007-04-01 | 2013-01-16 |
| Exendin(9-39)Amide as a Glucagon-like Peptide-1 (GLP-1) Receptor Antagonist in Humans GLP-1 control, GLP-1 and Exendin(9-39) 300, saline control - Hyperglycemia | Phase 1 | Completed | Ludwig-Maximilians - University of Munich | 6 | 2006-11-01 | 2011-10-04 |
| Evaluation of Three Continuation Therapies After ECT Concerning Efficacy and Cognition in Severly Depressed Patients TCAs, SSRIs, NARIs, SNRIs, Lithium, Electroconvulsive therapy, Cognitive behavioral group therapy - Depression, Major Depression | Phase 1 | Completed | Charite University, Berlin, Germany | 90 | 2005-03-01 | 2011-11-10 |
| Effects of Exendin(9-39) on Gastroduodenal Motility exendin(9-39)amide, atropine - Digestive Physiology, Gastrointestinal Motility | Phase 1 | Completed | Ludwig-Maximilians - University of Munich | 10 | 1999-02-01 | 2015-04-01 |
Depression (2) · Depressive Disorder, Major (2) · Anemia, Aplastic (1) · Coronary Artery Disease (1) · Depressive Disorder, Treatment-Resistant (1) · Epstein-Barr Virus Infections (1) · Hodgkin Disease (1) · Hyperglycemia (1) · Insulin Resistance (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Leukemia, Myeloid, Acute (1) · Lymphoma, Non-Hodgkin (1) · Melanoma (1) · Multiple Myeloma (1) · Myelodysplastic Syndromes (1)
exendin (9-39) (2) · Atropine (1) · Electroconvulsive Therapy (1) · Exercise (1) · Ghrelin (1) · Glucagon-Like Peptide 1 (1) · Granulocyte-Macrophage Colony-Stimulating Factor (1) · Interpersonal Psychotherapy (1) · Lithium (1) · Radiotherapy (1) · Selective Serotonin Reuptake Inhibitors (1) · Serotonin and Noradrenaline Reuptake Inhibitors (1) · Sunitinib (1) · Tobacco Use Cessation Devices (1) · glucagon-like peptide 1 (7-36)amide (1)
Germany (10) · Rwanda (1)
Joerg Schirra, MD (2) · Anita Kremer, MD,PhD (1) · Armin H Gerbitz, MD, PhD (1) · Axel Linke, MD (1) · Bernd Spriewald, MD, PhD (1) · Claus Garbe, Prof. Dr. (1) · Eva-Lotta Brakemeier, MA (1) · G. Winterer, Prof. Dr. (1) · Julia Winkler, MD (1) · Katja San Niccolo, MD (1) · Malek Bajbouj, PhD (1) · Norbert Kathmann, PhD (1) · Peter Hohenberger, MD PhD (1) · Susanne Schaal (1)
PMID 22160487, PMID 22452559, PMID 24048627, PMID 24462229, PMID 27255678, PMID 37965339, PMID 38467031, PMID 8550855, PMID 9525985